Three new studies have allayed fears that ACE inhibitors and Angiotensin Receptor Blockers (ARBs) may increase the risk of severe COVID-19 disease, with some showing they may even be beneficial. With the coronavirus known to enter cells via binding to the ACE2 receptor it had been thought that ACE inhibitors and ARBs would worsen susceptibility ...
ACE inhibitors and ARBs associated with better COVID-19 outcomes
By Michael Woodhead
24 Apr 2020